CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER
This Laos Patent “CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER” is a public DIP intellectual-property record, filed by OXFORD BIOTHERAPEUTICS LTD on 2014-10-10; current status: Abandoned. Identifiers include application No. P/421; DIP id LAP421; protection kind Patent - PCT National Phase. Key dates: publication 2025-10-03. Classification: A61K 39/00、A61K 47/48、C07K 16/28、C07K 16/30. Inventor(s)/designer(s): ACKROYD, James Edward, TERRETT, Jonathan Alexander. Abstract hint: The invention provides antibodies which bind to LY75. Nucleic acid molecules encoding the antibodies, expression vectors, host cells and me…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
P/421
Mark
Key facts
- Type
- Patent
- App. no.
P/421- Status
- Abandoned
- Applicant
- OXFORD BIOTHERAPEUTICS LTD
- Agent
- Lao Trademark Agency
- Filing date
- 2014-10-10
- Publication
- 2025-10-03
- Protection kind
- Patent - PCT National Phase
- Priority
- US · 61/890,098 · 2013-10-11；US · 61/890,104 · 2013-10-11
- Applicant address
- OXFORD BIOTHERAPEUTICS LTD · 94A Innovation Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RZ, Great Britain · GB
- Agent address
- Lao Trademark Agency · LLC Bldg, Nongbone Road, Ban Nongbone, Saysettha District, P.O. Box: 925, Vientiane, LAO P.D.R · LA
- Nice / IPC classes
- A61K 39/00 · A61K 47/48 · C07K 16/28 · C07K 16/30
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination Refused / terminated
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
The invention provides antibodies which bind to LY75. Nucleic acid molecules encoding the antibodies, expression vectors, host cells and methods for expressing the antibodies are also provided. The antibodies may be used for the treatment of cancer, including pancreatic cancer, ovarian cancer, breast cancer, colorectal cancer, esophageal cancer, skin cancer, thyroid cancer, lung cancer, multiple myeloma and lymphoma.
The invention provides antibodies which bind to LY75. Nucleic acid molecules encoding the antibodies, expression vectors, host cells and methods for expressing the antibodies are also provided. The antibodies may be used for the treatment of cancer, including pancreatic cancer, ovarian cancer, breast cancer, colorectal cancer, esophageal cancer, skin cancer, thyroid cancer, lung cancer, multiple myeloma and lymphoma.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP421.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP421.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP421.html?lang=en · CC BY 4.0